Double Blind Trial in Children With Autism Spectrum Disorder

Status:
Completed

Trial end date:
2021-03-15

Target enrollment:

Participant gender:

This study investigated the safe and efficacious use of suramin as a novel treatment for ASD by testing two suramin doses vs placebo

Phase 2

Paxmedica

Suramin